Abstract
Daratumumab after Allogeneic Hematopoietic Stem Cell Transplantation in Multiple Myeloma: Safety and Efficacy. a Retrospective Study from the Cmwp EBMT
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have